These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33346093)

  • 1. Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
    Mierzwa ML; Gharzai LA; Li P; Wilkie JR; Hawkins PG; Aryal MP; Lee C; Rosen B; Lyden T; Blakely A; Chapman CH; Thamarus J; Schonewolf C; Shah J; Eisbruch A; Schipper MJ; Cao Y
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):566-573. PubMed ID: 33346093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.
    Truong MT; Lee R; Saito N; Qureshi MM; Ozonoff A; Romesser PB; Wang J; Sakai O
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e119-27. PubMed ID: 21669502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma.
    Gharzai LA; Li P; Schipper MJ; Yao J; Mayo CS; Wilkie JR; Hawkins PG; Lyden T; Blakely A; Ibrahim M; Schonewolf CA; Shah J; Eisbruch A; Casper K; Mierzwa M
    Oral Oncol; 2020 Dec; 111():104853. PubMed ID: 32805634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
    Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
    Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
    Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
    Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
    Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
    Hedström J; Tuomi L; Finizia C; Olsson C
    Clin Transl Radiat Oncol; 2019 Nov; 19():87-95. PubMed ID: 31646203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-Associated Chronic Dysphagia Assessment by Flexible Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients: Swallowing-Related Structures and Radiation Dose-Volume Effect.
    Ozkaya Akagunduz O; Eyigor S; Kirakli E; Tavlayan E; Erdogan Cetin Z; Kara G; Esassolak M
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):73-84. PubMed ID: 30343589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
    Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
    Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
    Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
    Christianen ME; Schilstra C; Beetz I; Muijs CT; Chouvalova O; Burlage FR; Doornaert P; Koken PW; Leemans CR; Rinkel RN; de Bruijn MJ; de Bock GH; Roodenburg JL; van der Laan BF; Slotman BJ; Verdonck-de Leeuw IM; Bijl HP; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):107-14. PubMed ID: 21907437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
    Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
    Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation.
    Tsai CJ; Jackson A; Setton J; Riaz N; McBride S; Leeman J; Kowalski A; Happersett L; Lee NY
    JCO Clin Cancer Inform; 2017 Nov; 1():1-7. PubMed ID: 30657398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy.
    Ray X; Sumner W; Sutton L; Sanghvi P; Deichaite I; Moiseenko V
    J Transl Med; 2021 Sep; 19(1):380. PubMed ID: 34493300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.